Genelux
Genelux is a United States-based biotechnology company running 2 late-stage cancer trials of olvimulogene nanivacirepvec and Olvimulogene nanivacirepvec in ovarian cancer and non-small-cell lung cancer.
Overview
Genelux, based in Westlake Village, CA, the United States, is a biotechnology company. Genelux is a biopharmaceutical company developing oncolytic immunotherapies based on a modified vaccinia virus platform. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing olvimulogene nanivacirepvec and Olvimulogene nanivacirepvec in ovarian cancer and non-small-cell lung cancer. The largest, NCT05281471 (Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)), plans to enrol 186 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 3 +3
- modalities +2
Similar pages
not linked directly; found by shared links- CompanyNanjing Leads Biolabs
Shares Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyBioInvent International
Shares Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyHaihe Biopharma
Shares Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyInxMed (Shanghai)
Shares Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyAvistone Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMaia Biotechnology
Shares Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyNuvation Bio
Shares Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.